These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 15000344)
1. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes. Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947 [TBL] [Abstract][Full Text] [Related]
3. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy. Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384 [TBL] [Abstract][Full Text] [Related]
4. Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population. Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Nieminen MS; Laakso M; Kuusisto J; ; Kervinen H; Mustonen J; Juvonen J; Niemi M; Uusimaa P; Huttunen M; Kotila M; Pietilä M Ann Med; 2013 Feb; 45(1):85-90. PubMed ID: 22462493 [TBL] [Abstract][Full Text] [Related]
5. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640 [TBL] [Abstract][Full Text] [Related]
7. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy. Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380 [TBL] [Abstract][Full Text] [Related]
8. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239 [TBL] [Abstract][Full Text] [Related]
9. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Erdmann J; Daehmlow S; Wischke S; Senyuva M; Werner U; Raible J; Tanis N; Dyachenko S; Hummel M; Hetzer R; Regitz-Zagrosek V Clin Genet; 2003 Oct; 64(4):339-49. PubMed ID: 12974739 [TBL] [Abstract][Full Text] [Related]
10. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan. Chiou KR; Chu CT; Charng MJ J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479 [TBL] [Abstract][Full Text] [Related]
11. Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy. Ojala M; Prajapati C; Pölönen RP; Rajala K; Pekkanen-Mattila M; Rasku J; Larsson K; Aalto-Setälä K Stem Cells Int; 2016; 2016():1684792. PubMed ID: 27057166 [TBL] [Abstract][Full Text] [Related]
12. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Daehmlow S; Erdmann J; Knueppel T; Gille C; Froemmel C; Hummel M; Hetzer R; Regitz-Zagrosek V Biochem Biophys Res Commun; 2002 Oct; 298(1):116-20. PubMed ID: 12379228 [TBL] [Abstract][Full Text] [Related]
13. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy. Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498 [TBL] [Abstract][Full Text] [Related]
14. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. Mörner S; Richard P; Kazzam E; Hellman U; Hainque B; Schwartz K; Waldenström A J Mol Cell Cardiol; 2003 Jul; 35(7):841-9. PubMed ID: 12818575 [TBL] [Abstract][Full Text] [Related]
15. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy. Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408 [TBL] [Abstract][Full Text] [Related]
16. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans. Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316 [TBL] [Abstract][Full Text] [Related]
19. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. Jääskeläinen P; Soranta M; Miettinen R; Saarinen L; Pihlajamäki J; Silvennoinen K; Tikanoja T; Laakso M; Kuusisto J J Am Coll Cardiol; 1998 Nov; 32(6):1709-16. PubMed ID: 9822100 [TBL] [Abstract][Full Text] [Related]
20. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. Erdmann J; Raible J; Maki-Abadi J; Hummel M; Hammann J; Wollnik B; Frantz E; Fleck E; Hetzer R; Regitz-Zagrosek V J Am Coll Cardiol; 2001 Aug; 38(2):322-30. PubMed ID: 11499719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]